Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576309 | PMC |
| http://dx.doi.org/10.3389/fpsyt.2024.1504429 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nuclear cGAS mediated Replication Stress and Mitotic Catastrophe can Overcome Gemcitabine Resistance.
Cancer Lett
September 2025
Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health and Sciences University, Portland, OR, USA; Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, OR, USA.
Gemcitabine, a ribonucleotide reductase (RNR) inhibitor, is active in pancreatic ductal carcinoma (PDAC) patients, but unfortunately has a limited impact on long term outcomes. Gemcitabine induces nucleotide deficiency, DNA damage including single stranded DNA (ssDNA) and replication stress (RS). DNA damage can activate cyclic GMP-AMP synthase (cGAS), leading to genome instability, micronucleus generation, and immune activation.
View Article and Find Full Text PDFBreaking embolic ground: the clot thickens in intermediate-risk pulmonary embolism.
Eur Heart J Open
September 2025
Department of Cardiology, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Breaking the Cycle of Bullying in Nursing Workplaces.
Int J Ment Health Nurs
October 2025
Faculty of Medicine and Health, University of New England, Tamworth, New South Wales, Australia.
Breaking the Ice with Persistent Atrial Fibrillation Ablation: Is the Posterior Wall Worth the Freeze?
JACC Clin Electrophysiol
August 2025
Electrophysiology Section, Division of Cardiology; University of Michigan, Ann Arbor, MI. Electronic address: